Cox proportional hazards analysis also showed that overall survival of adenocarcinoma patients with reduced RUNX1 expression was approximately 1.97 (95% CI = 1.16–3.44; p = 0.01) times poorer than in those without, after controlling for age, recurrence, and pathologic stage (Table 1). Here, RUNX1 is linked to adenocarcinoma.